Earnings Feed
Start Free
Home/Insiders/Collins Charles Edwin IV
CC
SEC Insider//CIK 0001791800

Collins Charles Edwin IV

CIK 00017918001 companyARLINGTON, VA
SEC Profile

Transactions

50

Companies

1

Filings

2

CIK

0001791800

Recent Transactions

50 trades
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2026-04-21$33.81/sh−5,235→ 2,332 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-21$33.81/sh+5,235→ 40,555 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-21$148.72/sh+333→ 41,388 total
  • Sale
    ARGAN INC$AGX

    Common Stock

    2026-04-21$621.61/sh−11,068→ 30,320 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-21$36.78/sh+5,000→ 35,320 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2026-04-21$36.78/sh−5,000→ 7,567 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2026-04-21$148.72/sh−333→ 1,499 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-21$61.22/sh+500→ 41,055 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2026-04-21$61.22/sh−500→ 1,832 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2026-04-20$39.47/sh−2,500→ 12,567 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-20$39.47/sh+2,500→ 32,820 total
  • Sale
    ARGAN INC$AGX

    Common Stock

    2026-04-20$610.00/sh−2,500→ 30,320 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Time Based Restricted Stock Units

    2026-04-17−1,666→ 2,898 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Earnings Per Share Performance Based Restricted Stock Units

    2026-04-17−2,500→ 7,618 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-17+1,125→ 26,852 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Performance Based Restricted Stock Units

    2026-04-17−1,000→ 1,670 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-17+2,531→ 29,383 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-17+2,813→ 25,727 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-17+937→ 30,320 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Renewable Performance Based Restricted Stock Units

    2026-04-17−4,500→ 5,000 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Renewable Performance Based Restricted Stock Units

    2026-04-16−500→ 9,500 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-16+548→ 21,554 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Time Based Restricted Stock Units

    2026-04-16−1,333→ 5,231 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-16+730→ 22,554 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-16+360→ 22,914 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2026-04-16+270→ 21,824 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Renewable Performance Based Restricted Stock Units

    2026-04-16−1,000→ 10,000 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Time Based Restricted Stock Units

    2026-04-16−667→ 4,564 total
  • Award
    ARGAN INC$AGX

    Earnings Per Share Performance Based Restricted Stock Units

    2026-04-08+2,618→ 10,118 total
  • Award
    ARGAN INC$AGX

    Time Based Restricted Stock Units

    2026-04-08+231→ 6,564 total
  • Award
    ARGAN INC$AGX

    Performance Based Restricted Stock Units

    2026-04-08+170→ 2,670 total
  • Award
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2026-04-08+332→ 15,067 total
  • Sale
    ARGAN INC$AGX

    Common Stock

    2025-10-15$309.37/sh−10,000→ 21,006 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2025-10-15$42.31/sh+5,235→ 26,241 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2025-10-15$33.81/sh−4,765→ 14,735 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2025-10-15$42.31/sh−5,235→ 19,500 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2025-10-15$33.81/sh+4,765→ 31,006 total
  • Sale
    ARGAN INC$AGX

    Common Stock

    2025-10-13$292.09/sh−10,000→ 21,006 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2025-10-13$43.10/sh+5,235→ 26,241 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2025-10-13$43.10/sh−5,235→ 29,500 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2025-10-13$42.31/sh+4,765→ 31,006 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2025-10-13$42.31/sh−4,765→ 24,735 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2025-10-01$43.10/sh+5,000→ 26,006 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2025-10-01$43.10/sh−5,000→ 34,735 total
  • Sale
    ARGAN INC$AGX

    Common Stock

    2025-10-01$275.00/sh−5,000→ 21,006 total
  • Sale
    ARGAN INC$AGX

    Common Stock

    2025-09-24$267.00/sh−5,000→ 21,006 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2025-09-24$43.10/sh+5,000→ 26,006 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2025-09-24$43.10/sh−5,000→ 39,735 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Option to Purchase Common Stock

    2025-09-18$43.10/sh−7,500→ 44,735 total
  • Exercise/Conversion
    ARGAN INC$AGX

    Common Stock

    2025-09-18$43.10/sh+7,500→ 28,506 total

Companies

1

Recent Filings

2

Address

C/O ARGAN, INC. 4075 WILSON BLVD, SUITE 440

ARLINGTON, VA, 22203

View on SEC.gov